Immuneering Corporation financial statements
Immuneering Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 56.02M | 10-K |
| Cash and equivalents | USD 128.65M | 10-Q |
Immuneering Corporation financials on 6ix · Immuneering Corporation on 6ix